One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Subscription Information
doi : 10.1016/S0085-2538(24)00275-8
Volume 105, Issue 6, June 2024, Page A2
Time for action: recognizing chronic kidney disease as a major noncommunicable disease driver of premature mortality
Germaine Wong 1, Amélie Bernier-Jean 2, Brad Rovin 3, Pierre Ronco 4 5, Editors of Kidney International
doi : 10.1016/j.kint.2024.03.020
Volume 105, Issue 6, June 2024, Pages 1144-1146
Characterizing the cellular and molecular landscape of mineralocorticoid action and antagonism in the kidney
Verónica Miguel 1, Tilman B. Drueke 2
doi : 10.1016/j.kint.2023.12.016
Volume 105, Issue 6, June 2024, Pages 1150-1153
The tragedy of mitotic catastrophe in podocytes
Stuart J. Shankland 1 2, Behzad Najafian 3, Oliver Wessely 4
doi : 10.1016/j.kint.2024.01.015
Volume 105, Issue 6, June 2024, Pages 1153-1156
Not too much, not too little—just the right amount: the story of YAP in the podocyte
CaitrÃona M. McEvoy 1 2, Darren A. Yuen 3 4 5
doi : 10.1016/j.kint.2024.02.016
Volume 105, Issue 6, June 2024, Pages 1157-1159
Challenges in the development of novel methodologies for measuring glomerular filtration rate
Edward J. Johns 1
doi : 10.1016/j.kint.2024.03.022
Volume 105, Issue 6, June 2024, Pages 1159-1161
Prognostic implications of unbiased molecular categorization in kidney disease
Michael T. Eadon 1
doi : 10.1016/j.kint.2024.02.019
Volume 105, Issue 6, June 2024, Pages 1162-1164
Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
Mark Haas 1
doi : 10.1016/j.kint.2024.03.021
Volume 105, Issue 6, June 2024, Pages 1165-1167
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect
Kevin Yau 1 2, David Z.I. Cherney 1 2, Daniël H. van Raalte 3 4 5, Britt E. Wever 3 4
doi : 10.1016/j.kint.2024.03.019
Volume 105, Issue 6, June 2024, Pages 1168-1172
SGLT2 inhibitors act as metabolic transducers to restore healthy nutrient deprivation and surplus signaling in the kidney
Shinji Kume 1, Milton Packer 2 3
doi : 10.1016/j.kint.2024.01.044
Volume 105, Issue 6, June 2024, Pages 1172-1176
SGLT2 inhibitor: 2-way superstar in nephrology?
Masaomi Nangaku 1
doi : 10.1016/j.kint.2024.03.017
Volume 105, Issue 6, June 2024, Pages 1176-1177
Cutting back on low-value health care practices supports sustainable kidney care
Scott McAlister 1 2, Valerie A. Luyckx 3 4 5, Andrea K. Viecelli 6 7
doi : 10.1016/j.kint.2023.12.022
Volume 105, Issue 6, June 2024, Pages 1178-1185
Single-cell lineage tracing approaches to track kidney cell development and maintenance
Baul Yoon 1, Hayoung Kim 1, Su Woong Jung 2 3, Jihwan Park 1
doi : 10.1016/j.kint.2024.01.045
Volume 105, Issue 6, June 2024, Pages 1186-1199
Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury
Jianchun Chen 1 2 3, Xiaoyong Wang 2, Qian He 2, Hai-Chun Yang 2 4, Agnes B. Fogo 2 4, Raymond C. Harris 1 2 3 5
doi : 10.1016/j.kint.2024.01.038
Volume 105, Issue 6, June 2024, Pages 1200-1211
Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease
Tobias T. Pieters 1 4, Paul J. Besseling 1 4, Dominique M. Bovée 2, Maarten B. Rookmaaker 1, Marianne C. Verhaar 1, Benito Yard 3, Ewout J. Hoorn 2, Jaap A. Joles 1
doi : 10.1016/j.kint.2024.02.020
Volume 105, Issue 6, June 2024, Pages 1212-1220
Paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 transcription
Yue Lu 1, Linlin Meng 1, Ruiqing Ren 1, Xinlu Wang 1, Wenhai Sui 1, Fei Xue 1, Lin Xie 1, Ang Chen 1, Yuxia Zhao 1 2, Jianmin Yang 1, Wencheng Zhang 1, Xiao Yu 3, Bo Xi 4, Feng Xu 5, Meng Zhang 1 6, Yun Zhang 1 6, Cheng Zhang 1 6
doi : 10.1016/j.kint.2024.01.039
Volume 105, Issue 6, June 2024, Pages 1221-1238
Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition
Jeonghwan Lee 1 2 11, Jinhaeng Lee 3 11, Kyuhong Kim 4 11, Jiwon Lee 4, Youngae Jung 3, Jin Seong Hyeon 3, Areum Seo 5, Wencheng Jin 1 2, Boram Weon 2 6, Nayeon Shin 2, Sejoong Kim 1 7, Chun Soo Lim 1 2, Yon Su Kim 1 6, Jung Pyo Lee 1 2 12, Geum-Sook Hwang 3 8 12, Seung Hee Yang 9 10 12
doi : 10.1016/j.kint.2024.01.040
Volume 105, Issue 6, June 2024, Pages 1239-1253
Determining individual glomerular proteinuria and periglomerular infiltration in a cleared murine kidney by a 3-dimensional fast marching algorithm
Alexander M.C. Böhner 1 2 7, Alexander Effland 3 7, Alice M. Jacob 1, Karin A.M. Böhner 1, Zeinab Abdullah 1, Sebastian Brähler 4, Ulrike I. Attenberger 2, Martin Rumpf 5, Christian Kurts 1 6
doi : 10.1016/j.kint.2024.01.043
Volume 105, Issue 6, June 2024, Pages 1254-1262
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine
Anna Reznichenko 1, Viji Nair 2, Sean Eddy 2, Damian Fermin 2, Mark Tomilo 2, Timothy Slidel 3, Wenjun Ju 2, Ian Henry 4, Shawn S. Badal 5, Johnna D. Wesley 6, John T. Liles 5, Sven Moosmang 1, Julie M. Williams 7, Carol Moreno Quinn 8, Markus Bitzer 2, Jeffrey B. Hodgin 2 9, Laura Barisoni 10 11, Anil Karihaloo 6, Matthew D. Breyer 12, Kevin L. Duffin 13…Matthias Kretzler 2 15
doi : 10.1016/j.kint.2024.01.012
Volume 105, Issue 6, June 2024, Pages 1263-1278
Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy
Shubha S. Bellur 1, Stéphan Troyanov 2, Olga Vorobyeva 3, Rosanna Coppo 4, Ian S.D. Roberts 5
doi : 10.1016/j.kint.2024.03.011
Volume 105, Issue 6, June 2024, Pages 1279-1290
Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis
Yusho Ueda 1, Daigo Nakazawa 1, Saori Nishio 1, Satoka Shiratori-Aso 1, Takashi Kudo 1, Atsuko Miyoshi-Harashima 1, Kanako Watanabe-Kusunoki 1, Fumihiko Hattanda 1, Sari Iwasaki 2, Takahiro Tsuji 2, Utano Tomaru 3, Yasuaki Aratani 4, Mamiko Yamamoto 5, Akihiro Ishizu 5, Tatsuya Atsumi 1
doi : 10.1016/j.kint.2024.03.010
Volume 105, Issue 6, June 2024, Pages 1291-1305
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
Richard Lafayette 1, Sean Barbour 2, Rubeen Israni 3, Xuelian Wei 4, Necmi Eren 5, Jürgen Floege 6, Vivekanand Jha 7 8 9, Sung Gyun Kim 10, Bart Maes 11, Richard K.S. Phoon 12, Harmeet Singh 13, VladimÃr Tesař 14, Celia J.F. Lin 15, Jonathan Barratt 16
doi : 10.1016/j.kint.2024.03.012
Volume 105, Issue 6, June 2024, Pages 1306-1315
NELL-1–associated membranous nephropathy linked to skin fairness cream use: insights from an Indian case series
Ranjit Narayanan 1, Sajeesh Sivadas 1, Anila Abraham Kurien 2
doi : 10.1016/j.kint.2024.03.025
Volume 105, Issue 6, June 2024, Pages 1316-1319
Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy
Jordi Rovira 1, Carolt Arana 1 2, Ainhoa Garcia-Busquets 1, Ilse Gille 3 4, LuÃs F. Quintana 1 2, Mirjam H.M. Heemskerk 4, Sebastiaan Heidt 3 5, Eduard Palou 6, Fritz Diekmann 1 2
doi : 10.1016/j.kint.2024.03.007
Volume 105, Issue 6, June 2024, Page 1320
The authors reply
Boris Fehse 1 2, Nicola M. Tomas 2 3
doi : 10.1016/j.kint.2024.03.006
Volume 105, Issue 6, June 2024, Pages 1320-1321
Bridging the knowledge–practice gap in kidney care: insights from a medical student in Thailand
Abhishet Varama 1
doi : 10.1016/j.kint.2024.03.014
Volume 105, Issue 6, June 2024, Page 1321
The authors reply
Winston W.S. Fung 1, Valerie A. Luyckx 2 3 4, Katherine R. Tuttle 5 6, writing team and the World Kidney Day Joint Steering Committee
doi : 10.1016/j.kint.2024.03.015
Volume 105, Issue 6, June 2024, Pages 1321-1322
Implementation science: a tool to narrow know-do gap and widen equity in kidney diseases and transplantation
Ekamol Tantisattamo 1 2 3
doi : 10.1016/j.kint.2024.03.016
Volume 105, Issue 6, June 2024, Pages 1322-1323
The authors reply
Winston W.S. Fung 1, Valerie A. Luyckx 2 3 4, Katherine R. Tuttle 5 6
doi : 10.1016/j.kint.2024.03.013
Volume 105, Issue 6, June 2024, Pages 1323-1324
Diagnosis of pseudo-acute kidney injury: mesothelial cells in the urine
Satoshi Kurahashi 1, Naohiro Toda 1, Ryo Sato 1, Kyoka Fujita 1, Jun Takeoka 1, Akira Ishii 1, Masaaki Fujita 2, Toshiyuki Komiya 1
doi : 10.1016/j.kint.2023.12.020
Volume 105, Issue 6, June 2024, Page 1325
Renal artery microaneurysms in antineutrophil cytoplasmic antibody–associated vasculitis
Jiale Tang 1 2, Zhou Xiao 1 2, Liang Liu 1, Xiaozhao Li 1
doi : 10.1016/j.kint.2023.12.019
Volume 105, Issue 6, June 2024, Page 1326
The Case | An active injection drug user with a skin rash and kidney failure
Abraham W. Aron 1, Randy L. Luciano 2
doi : 10.1016/j.kint.2024.03.009
Volume 105, Issue 6, June 2024, Pages 1327-1328
Corrigendum to “Are biomarkers in acute kidney injury ready for prime time? The time is right for a second look.� Kidney Int. 2024;105:675–678
Chirag R. Parikh 1, Steven G. Coca 2
doi : 10.1016/j.kint.2024.04.007
Volume 105, Issue 6, June 2024, Page 1329
